Sanofi, Doudna-founded Scribe Therapeutics to target sickle cell disease in new pact
Endpoints News
|
July 17, 2023
X min read
Endpoints News
|
July 17, 2023
Share on Social
More like this
News
Scribe Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 15, 2025
Read Now
Press
Scribe Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 15, 2025
Read Now
